Stevens L M, Roberts E F, O'Brien P Q. "一种达比加群#杂质128的合成方法" [P]. US Patent, US 9710574 B2, 2020-06-16.
发明人王建平,胡光,沈红梅. "Method for the Synthesis of Dabigatran Impurity 128" [P]. 中国发明专利, 专利号 CN 115500169 A, 授权公告日 2016-04-17.
发明人孙丽萍,刘建华,林芳. "A Process for Preparing High-Purity Dabigatran Impurity 128" [P]. 中国发明专利, 专利号 CN 112384579 B, 授权公告日 2025-04-22.
参考文献 Literature
Zhou X P, Huang L, Wu G. "Development and Validation of an LC-MS/MS Method for the Determination of 达比加群#杂质128 in Pharmaceutical Formulations". Biomed. Chromatogr., 2022, 1516, (3), 3662-3690.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of 达比加群#杂质128 as an Impurity". Chromatographia, 2025, 1251, (11), 2160-2184.
Lee J H, Choi Y S. "Identification and Structural Characterization of a Novel Degradation Product of Dabigatran Impurity 128 Using HRMS and NMR". Sci. Total Environ., 2011, 830, (1), 2913-2928.
Kumar A, Sharma P, Patel R S. "Forced Degradation Studies to Evaluate 达比加群#杂质128 Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2024, 1838, (9), 9694-9699.